Celine Haliqua

Founder & CEO

2020 - Current

Developing drugs to extend dogs' healthy lifespan

Chief of Staff

2019 - 2020

Entrepreneur In Residence

2018 - 2020

Venture capital fund investing in therapies with the potential to extend human lifespan.

Scientific Consultant

2017 - 2018

Pre-clinical biotechnology company developing senolytic and oncolytic therapeutics utilizing proprietary technology driven by cellular activity levels.

Researcher: Neuro-oncology

2015 - 2016

Designed and conducted a pilot project investigating a novel drug-delivery mechanism in vitro on murine neuronal stemlike cell line C17.2 and patient-derived glioblastoma cell lines. Laboratory of Dr. Evan Snyder.

Research Assistant - Neuropharmacology

2014 - 2015

Investigated the effect of ethanol on the dopaminergic reward pathway in a mouse model. Managed mice care, ran operant chambers, conducted aseptic stereotaxic survival surgery, and prepared brains for electrophysiology experiments and histological staining. Conducted independent project testing the biocompatibility and neuronal uptake of DNA-templated silver nanoclusters injected into the mouse nucleus accumbens.

Research Assistant & Mentor - Nanochemistry

2014 - 2015

Synthesized nanoparticles and tested their catalytic properties. Worked extensively with super-paramagnetic iron oxide nanoparticles and fluorescent DNA-templated silver nanoclusters. Led and mentored new students in the lab, teaching relevant laboratory techniques and ensuring safety.

Policy Advisory Committee

2014 - 2015

Assisted in development of The University of Texas at Austin’s newly opened medical school’s student conduct handbook. Sat on medical professionalism committee, focusing on student doctor competence and self-improvement.